Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial

Obesity (Silver Spring). 2013 Dec;21(12):E660-8. doi: 10.1002/oby.20522. Epub 2013 Aug 13.

Abstract

Objective: Increased delivery of bile acid salts (BA) to distal L-cells and altered TGR5 receptor activation may contribute to the early and substantial increases in gut peptide secretion seen after bariatric surgery. To further elucidate a potential role of BA in the secretion of GLP-1 and PYY, we analyzed plasma BA concentrations in 14 morbidly obese patients undergoing gastric bypass or sleeve gastrectomy in a prospective, randomized 1-year trial.

Design and methods: Patients received a standard test meal and blood was collected before and after eating, prior to, and 1 week, 3 months, and 12 months after surgery.

Results: Pre-surgery, basal BA concentrations were significantly lower in bariatric patients than in healthy controls. One year post-surgery, bariatric patients expressed variably increased BA concentrations (gastric bypass patients ∼2 fold increase, P ≤ 0.05). However, whereas in both patient groups, marked increases in GLP-1 and PYY and improved glycemic control was seen already 1 week and 3 months post-surgery, changes in plasma BA followed a different pattern: basal and postprandial plasma BA concentrations increased much slower, more progressively with significant increases only 1-year post-surgery.

Conclusions: Based on these findings, BA do not appear to be key mediators of the early increase in GLP-1 and PYY response in post-bariatric patients.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bile Acids and Salts / blood*
  • Bile Acids and Salts / metabolism*
  • Blood Glucose / metabolism
  • Body Mass Index
  • Body Weight
  • Gastrectomy
  • Gastric Bypass*
  • Glucagon-Like Peptide 1 / blood
  • Humans
  • Obesity, Morbid / blood
  • Obesity, Morbid / surgery
  • Peptide YY / blood
  • Pilot Projects
  • Postprandial Period
  • Prospective Studies

Substances

  • Bile Acids and Salts
  • Blood Glucose
  • Peptide YY
  • Glucagon-Like Peptide 1